BUZZ-Valeant's dim forecast infects specialty pharma stocks

Tue Mar 15, 2016 10:21am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Shares of specialty pharmaceutical cos get clipped after beleaguered Valeant Pharmaceuticals slashes its 2016 forecast

** U.S.-listed Valeant shares now down 40 pct to more than 4-year low

** Mallinckrodt and Endo International fall in sympathy and among biggest S&P 500 index losers, both down nearly 7 pct; Horizon Pharma PLC drops 9 pct

** Trader says Valeant's woes should be less of a fundamental read across to Mylan NV and Teva Pharmaceutical Industries ; MYL down 3 pct, U.S.-listed TEVA shares off 4 pct

** Specialty pharma stocks have been hurt by questions facing Valeant over pricing and other business practices

(RM: lance.tupper.tr.com@reuters.net)